Pages that link to "Q34528705"
Jump to navigation
Jump to search
The following pages link to Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers (Q34528705):
Displaying 11 items.
- Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers (Q35153890) (← links)
- Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases (Q38367206) (← links)
- Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases (Q38672468) (← links)
- Comparison of low-dose antacids, cimetidine, and placebo on 24-hour intragastric acidity in healthy volunteers (Q39233888) (← links)
- Optimizing acid suppression for treatment of acid-related diseases (Q40595569) (← links)
- Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease (Q41445264) (← links)
- Interaction of magnesium oxide with gastric acid secretion inhibitors in clinical pharmacotherapy (Q43317474) (← links)
- Chronic omeprazole treatment increases duodenal susceptibility to ethanol injury in rats (Q43699283) (← links)
- Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer (Q63199423) (← links)
- A comparative study of once-a-day morning and once-a-day bedtime administration of 40 mg famotidine in treating duodenal ulcers (Q68111173) (← links)
- Histamine H2-receptor antagonists (Q69924326) (← links)